RSCM
CRVO icon

Rock Springs Capital Management’s CervoMed CRVO Stock Holding History

Rock Springs Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80,033
Closed -$370K – 106
2023
Q3 		$370K Buy
+80,033
New +$403K 0.01% 113

Other funds holding CRVO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Rock Springs Capital Management's CRVO Position: Q4 2023 in Review

Rock Springs Capital Management sold out of CervoMed (CRVO) in Q4 2023, closing a stake of 80,033 shares — an estimated $370K sold.

Rock Springs Capital Management first reported a position in CRVO in Q3 2023 and held it in 1 quarter. The position peaked at $370K in Q3 2023. 12 funds tracked by Wall St. Rank hold CRVO as of Q4 2023.

  • Rock Springs Capital Management reported no remaining CervoMed position as of Q4 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 80,033 CervoMed shares in Q4 2023, an estimated $370K.
  • Rock Springs Capital Management first reported a position in CervoMed in Q3 2023 and held it in 1 quarter.
  • Rock Springs Capital Management's CervoMed position peaked at $370K in Q3 2023.
  • 12 funds tracked by Wall St. Rank held CervoMed as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.